Berger J, Hinglais N. Les ddpôts intercapillaires d’IgA-IgG [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris). 1968;74:694–5.
Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–42.
Article CAS PubMed Google Scholar
Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: IgA nephropathy. Am J Kidney Dis. 2015;66:e33–4.
Masuda Y, Yamanaka N, Ishikawa A, Kataoka M, Arai T, Wakamatsu K, Kuwahara N, Nagahama K, Ichikawa K, Shimizu A. Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for α5(IV) and α2(IV) chains of type IV collagen and low-vacuum scanning electron microscopy. Clin Exp Nephrol. 2015;19:427–35.
Article CAS PubMed Google Scholar
Nakamoto Y, Yasuda T, Imai H, Miura AB. Circumferential mesangial interposition: a form of mesangiolysis. Nephrol Dial Transplant. 1992;7:373–8.
Hara M, Endo Y, Nihei H, Hara S, Fukushima O, Mimura N. IgA nephropathy with subendothelial deposits. Virchows Arch A Pathol Anat Histol. 1980;386:249–63.
Article CAS PubMed Google Scholar
Yoshikawa N, Ito H, Nakahara C, Yoshiara S, Yoshiya K, Matsuo T, Hasegawa O, Hazikano H, Okada S. Glomerular electron-dense deposits in childhood IgA nephropathy. Virchows Arch A Pathol Anat Histopathol. 1985;406:33–43.
Article CAS PubMed Google Scholar
Emancipator SN. IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis. 1994;23:451–62.
Article CAS PubMed Google Scholar
Iitaka K, Yamamoto A, Ogawa N, Sekine T, Tamai S, Motoyama O. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children. Clin Exp Nephrol. 2003;7:284–9.
Zhu J, Wang H, Yang D. IgA Nephropathy with Pathologic Features of membranoproliferative glomerulonephritis following Burn Injury. Case Rep Nephrol Urol. 2014;4:31–6.
Article PubMed PubMed Central Google Scholar
Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93:700–5.
Article CAS PubMed Google Scholar
Matsuzaki K, Suzuki H, Kikuchi M, Koike K, Komatsu H, Takahashi K, Narita I, Okada H, Committee of Clinical Practical Guideline for IgA Nephropathy. Current treatment status of IgA nephropathy in Japan: a questionnaire survey. Clin Exp Nephrol. 2020;2023(27):1032–41.
Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, Kurita N, Sasaki S, Nishiwaki H, Koizumi M, Saito S, Nishibori N, Oe Y, Yoshida M, Miyaoka Y, Akiyama S, Itano Y, Okazaki M, Ozeki T, Ichikawa D, Oguchi H, Kohsaka S, Kosaka S, Kataoka Y, Shima H, Shirai S, Sugiyama K, Suzuki T, Son D, Tanaka T, Nango E, Niihata K, Nishijima Y, Nozu K, Hasegawa M, Miyata R, Yazawa M, Yamamoto Y, Yamamoto R, Shibagaki Y, Furuichi K, Okada H, Narita I. A digest of the Evidence-Based Clinical Practice Guideline for nephrotic syndrome 2020. Clin Exp Nephrol. 2021;25:1277–85.
Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int. 2007;72:1429–47.
Article CAS PubMed Google Scholar
Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol. 2014;9:271–8.
Nakopoulou L. Membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 2001;16(Suppl 6):71–3.
Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–70.
Article CAS PubMed Google Scholar
Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis–a new look at an old entity. N Engl J Med. 2012;366:1119–31.
Article CAS PubMed Google Scholar
Ferrario G, Palazzi P, Torri Tarelli L, Volpi A, Meroni M, Giordano F, Sessa A. Membranoproliferative glomerulonephritis with IgA deposits in patients with alcoholic cirrhosis. Pathologica. 1986;78:469–78.
Andeen NK, Jefferson JA, Akilesh S, Alpers CE, Bissonnette ML, Finn LS, Higgins J, Houghton DC, Kambham N, Magil A, Najafian B, Nicosia RF, Troxell ML, Smith KD. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury. Hum Pathol. 2018;81:272–80.
Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS ONE. 2018;13: e0206865.
Article PubMed PubMed Central Google Scholar
Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, Ishimori S, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Yamamura T, Yoshimura M, Nakanishi K, Fujimura J, Kamiyoshi N, Nagase H, Yoshikawa N, Iijima K, Nozu K. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases. Sci Rep. 2020;10:14026.
Article CAS PubMed PubMed Central Google Scholar
Kurosu A, Oka N, Hamaguchi T, Yoshikawa N, Joh K. Infantile immunoglobulin A nephropathy showing features of membranoproliferative glomerulonephritis. Tohoku J Exp Med. 2012;228:253–8.
Utsunomiya Y, Kado T, Koda T, Okada S, Hayashi A, Fukawaza A, Nakagawa T, Kanzaki S, Kasagi T. Features of IgA nephropathy in preschool children. Clin Nephrol. 2000;54:443–8.
Yamaji K, Suzuki Y, Suzuki H, Satake K, Horikoshi S, Novak J, Tomino Y. The kinetics of glomerular deposition of nephritogenic IgA. PLoS ONE. 2014;9: e113005.
Article PubMed PubMed Central Google Scholar
Makita Y, Suzuki H, Nakano D, Yanagawa H, Kano T, Novak J, Nishiyama A, Suzuki Y. Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries. Nephrol Dial Transplant. 2022;37:1629–36.
Article CAS PubMed PubMed Central Google Scholar
Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis. 1987;9:404–9.
Article CAS PubMed Google Scholar
Kitamura M, Obata Y, Ota Y, Muta K, Yamashita H, Harada T, Mukae H, Nishino T. Significance of subepithelial deposits in patients diagnosed with IgA nephropathy. PLoS ONE. 2019;14: e0211812.
Article CAS PubMed PubMed Central Google Scholar
Katafuchi R, Ikeda K, Mizumasa T, Tanaka H, Ando T, Yanase T, Masutani K, Kubo M, Fujimi S. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy. Am J Kidney Dis. 2003;41:972–83.
Article CAS PubMed Google Scholar
Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria. Clin Exp Nephrol. 2020;24:927–34.
Article CAS PubMed Google Scholar
Coppo R, Amore A. New perspectives in treatment of glomerulonephritis. Pediatr Nephrol. 2004;19:256–65.
留言 (0)